| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.48 | 0.1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.1 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |